Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Mar 21, 2014
Insider Transaction Report
Form 4
Patterson Albert
Senior VP, Operations
Transactions
- Award
Common Stock
2014-03-19+841→ 39,174 total - Award
Stock Option to Buy
2014-03-19+1,459→ 1,459 totalExercise: $23.78Exp: 2024-03-19→ Common Stock (1,459 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments beginning on March 19, 2015.